Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

Cited by (286)

Items 101–200 of 286

  1. Copper(I) and Copper(II) Inhibit Aβ Peptides Proteolysis by Insulin‐Degrading Enzyme Differently: Implications for Metallostasis Alteration in Alzheimer’s Disease
    Giuseppe Grasso, Adriana Pietropaolo, Giuseppe Spoto, Giuseppe Pappalardo, Grazia Raffaella Tundo, Chiara Ciaccio, Massimo Coletta, Enrico Rizzarelli · 2011 · Chemistry - A European Journal
  2. Amyloid precursor protein traffics from the Golgi directly to early endosomes in an Arl5b‐ and AP4‐dependent pathway
    Toh, Wei Hong, Tan, Jing Zhi A., Zulkefli, Khalisah L., Houghton, Fiona J., Gleeson, Paul A. · 2017 · Traffic
  3. Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling
    Mario Nizzari, Stefano Thellung, Alessandro Corsaro, Valentina Villa, Aldo Pagano, Carola Porcile, Claudio Russo, Tullio Florio · 2012 · Journal of Toxicology
  4. Mapping Brain Metals to Evaluate Therapies for Neurodegenerative Disease
    Bogdan Florin Gh. Popescu, Helen K. Nichol · 2010 · CNS Neuroscience & Therapeutics
  5. Melatonin regulates the transcription of βAPP‐cleaving secretases mediated through melatonin receptors in human neuroblastoma SH‐SY5Y cells
    Jiraporn Panmanee, Chutikorn Nopparat, Napapit Chavanich, Mayuri Shukla, Sujira Mukda, Weihong Song, Bruno Vincent, Piyarat Govitrapong · 2015 · Journal of Pineal Research
  6. Intracellular Itinerary of Internalised β‐Secretase, BACE1, and Its Potential Impact on β‐Amyloid Peptide Biogenesis
    Chia, Pei Zhi Cheryl, Toh, Wei Hong, Sharples, Robyn, Gasnereau, Isabelle, Hill, Andrew F., Gleeson, Paul A. · 2013 · Traffic
  7. PET Imaging of Copper Trafficking in a Mouse Model of Alzheimer Disease
    Júlia Baguña Torres, Erica M. Andreozzi, Joel Dunn, Muhammad Siddique, Istvan Szanda, David R Howlett, Kavitha Sunassee, Philip J. Blower · 2015 · Journal of Nuclear Medicine
  8. The multi-layered regulation of copper translocating P-type ATPases
    Nicholas A. Veldhuis, Ann P. Gaeth, Richard B. Pearson, Kipros Gabriel, James Camakaris · 2009 · BioMetals
  9. The Cleavage Effect of Mesenchymal Stem Cell and Its Derived Matrix Metalloproteinase-2 on Extracellular α-Synuclein Aggregates in Parkinsonian Models
    Se Hee Oh, Hana Kim, Hyun-Jung Park, Jin Young Shin, Dong Yeol Kim, Phil Hyu Lee · 2016 · Stem Cells Translational Medicine
  10. Paradoxical Condensation of Copper with Elevated β-Amyloid in Lipid Rafts under Cellular Copper Deficiency Conditions
    Ya Hui Hung, Elysia L. Robb, Irene Volitakis, Michael Ho, Genevieve M. Evin, Qiao-Xin Li, Janetta Gladys Culvenor, Colin Louis Masters, Robert A. Cherny, Ashley Ian Bush · 2009 · Journal of Biological Chemistry
  11. Cu(II) interaction with amyloid-β peptide: A review of neuroactive mechanisms in AD brains
    Changjun Lin, Han‐Chang Huang, Zhao-Feng Jiang · 2010 · Brain Research Bulletin
  12. Metals in Alzheimer’s Disease
    Mirjana Babić Leko, Lea Langer Horvat, Ena Španić, Klara Zubčić, Patrick R. Hof, Goran Šimić · 2023 · Biomedicines
  13. Differential modulation of Alzheimer's disease amyloid β-peptide accumulation by diverse classes of metal ligands
    Aphrodite Caragounis, Tai Du, Gulay Filiz, Katrina M. Laughton, Irene Volitakis, Robyn A. Sharples, Robert A. Cherny, Colin Louis Masters, Simon C. Drew, Andrew Francis Hill et al. · 2007 · Biochemical Journal
  14. Magnesium Modulates Amyloid-β Protein Precursor Trafficking and Processing
    Jia Hui Yu, Miao Sun, Zheng Chen, Jiangyang Lu, Yi Liu, Liang Zhou, Xuemin Xu, Dongsheng Fan, Dehua Chui · 2010 · Journal of Alzheimer s Disease
  15. Twenty years of metallo-neurobiology: where to now?
    Ashley Ian Bush, Cyril C. Curtain · 2007 · European Biophysics Journal
  16. MMP‐9‐positive neutrophils are essential for establishing profibrotic microenvironment in the obstructed kidney of UUO mice
    Haidong Wang, Min Gao, Jiangbo Li, Jian Sun, Ran Wu, Deping Han, Jianmei Tan, Juan Wang, Bin Wang, Liping Zhang et al. · 2019 · Acta Physiologica
  17. Dual-function triazole–pyridine derivatives as inhibitors of metal-induced amyloid-β aggregation
    Michael R. Jones, E.L. Service, J. R. Thompson, Michael C. P. Wang, Isaac J. Kimsey, Alaina S. DeToma, Ayyalusamy Ramamoorthy, Mi Hee Lim, Tim Storr · 2012 · Metallomics
  18. Regulation of matrix metalloproteinase 2 by oligomeric amyloid β protein
    Wenjun Li, Ethan C. Poteet, Luokun Xie, Ran Liu, Yi Wen, Shao-Hua Yang · 2011 · Brain Research
  19. Evidence That CD147 Modulation of β-Amyloid (Aβ) Levels Is Mediated by Extracellular Degradation of Secreted Aβ
    Kulandaivelu S. Vetrivel, Xulun Zhang, Xavier Meckler, Haipeng Cheng, Sung‐Ho Lee, Ping Gong, Kryslaine L. Radomski, Ying Chen, Nobuhisa Iwata, Ke‐Jie Yin et al. · 2008 · Journal of Biological Chemistry
  20. Clioquinol Reduces Zinc Accumulation in Neuritic Plaques and Inhibits the Amyloidogenic Pathway in AβPP/PS1 Transgenic Mouse Brain
    Tao Wang, Chunyan Wang, Zhongyan Shan, Weiping Teng, Zhan‐You Wang · 2012 · Journal of Alzheimer s Disease
  21. Genetic Inhibition of Solute-Linked Carrier 39 Family Transporter 1 Ameliorates Aβ Pathology in a Drosophila Model of Alzheimer's Disease
    Minglin Lang, Lei Wang, Qiangwang Fan, Guiran Xiao, Xiaoxi Wang, Yi Zhong, Bing Zhou · 2012 · PLoS Genetics
  22. An update on pharmacological approaches to neurodegenerative diseases
    Roberto Scatena, Giuseppe Ettore Martorana, Patrizia Bottoni, Giorgia Botta, Paola Pastore, Bruno Giardina · 2006 · Expert Opinion on Investigational Drugs
  23. ADAM30 Downregulates APP-Linked Defects Through Cathepsin D Activation in Alzheimer's Disease
    Florent Letronne, Geoffroy O. Laumet, Anne‐Marie Ayral, Julien Chapuis, Florie Demiautte, Mathias Laga, Michel Erminio Vandenberghe, Nicolas Malmanche, Florence Leroux, Fanny Eysert et al. · 2016 · EBioMedicine
  24. Phosphorylation regulates copper-responsive trafficking of the Menkes copper transporting P-type ATPase
    Nicholas A. Veldhuis, Valentina A. Valova, Ann P. Gaeth, Nickless Palstra, Katherine M. Hannan, Belinda J. Michell, Leonard E. Kelly, Ian G. Jennings, Bruce E. Kemp, Richard B. Pearson et al. · 2009 · The International Journal of Biochemistry & Cell Biology
  25. Pharmacotherapeutic targets in Alzheimer's disease
    Yif'at Biran, Colin Louis Masters, Kevin Jeffrey Barnham, Ashley Ian Bush, Paul Anthony Adlard · 2008 · Journal of Cellular and Molecular Medicine
  26. Copper Chelators: Chemical Properties and Bio-medical Applications
    Matteo Tegoni, Daniela Valensin, Leonardo Toso, Maurizio Remelli · 2014 · Current Medicinal Chemistry
  27. The Anti-neurodegeneration Drug Clioquinol Inhibits the Aging-associated Protein CLK-1
    Ying Wang, Robyn S. Branicky, Zaruhi Stepanyan, Melissa Carroll, Marie-Pierre Guimond, Abdelmadjid K. Hihi, Steve T. Hayes, Kevin McBride, Siegfried Hekimi · 2008 · Journal of Biological Chemistry
  28. Trace elements and Alzheimer dementia in population-based studies: A bibliometric and meta-analysis
    Kai Li, Ang Li, Yayuan Mei, Jiaxin Zhao, Quan Zhou, Yanbing Li, Ming Yang, Qun Xu · 2022 · Environmental Pollution
  29. ABCA5 Regulates Amyloid-β Peptide Production and is Associated with Alzheimer's Disease Neuropathology
    YuHong Fu, Jen-Hsiang T. Hsiao, George Paxinos, Glenda Margaret Halliday, Woojin Scott Kim · 2014 · Journal of Alzheimer s Disease
  30. GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity
    Ilana Chefetz, Kimitoshi Kohno, Hiroto Izumi, Jouni Uitto, Gabriele Richard, Eli Sprecher · 2008 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  31. Selective Acetylcholinesterase Inhibitor Activated by Acetylcholinesterase Releases an Active Chelator with Neurorescuing and Anti-Amyloid Activities
    Hailin Zheng, Moussa B. H. Youdim, Mati Fridkin · 2010 · ACS Chemical Neuroscience
  32. Copper( ii ) complexes of hybrid hydroxyquinoline-thiosemicarbazone ligands: GSK3β inhibition due to intracellular delivery of copper
    James L. Hickey, Peter John Crouch, S. Mey, Aphrodite Caragounis, Jonathan Michael White, Anthony Robert White, Paul S. Donnelly · 2010 · Dalton Transactions
  33. β-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3
    Yulei Deng, Xiong Zhe, Paul Chen, Jing Wei, Shengdi Chen, Zhen Yan · 2013 · Neurobiology of Aging
  34. Pyrrolidine dithiocarbamate activates the Nrf2 pathway in astrocytes
    Jeffrey R. Liddell, Šárka Lehtonen, Clare Duncan, Velta Keksa-Goldsteine, Anna–Liisa Levonen, Gundars Goldsteins, Tarja Malm, Anthony Robert White, Jari Koıstınaho, Katja M. Kanninen · 2016 · Journal of Neuroinflammation
  35. Matrix metalloproteinases-2 and -3 are reduced in cerebrospinal fluid with low beta-amyloid1–42 levels
    Reinhilde Mlekusch, Christian Humpel · 2009 · Neuroscience Letters
  36. Abnormal Expression and Distribution of MMP2 at Initial Stages of Alzheimer’s Disease-Related Pathology
    Beatrice Terni, Isidró Ferrer · 2015 · Journal of Alzheimer s Disease
  37. Copper and clioquinol treatment in young APP transgenic and wild-type mice: effects on life expectancy, body weight, and metal-ion levels
    S Schäfer, Frank–Gerald Pajonk, Gerd Multhaup, Thomas A. Bayer · 2007 · Journal of Molecular Medicine
  38. The Metal Chelating and Chaperoning Effects of Clioquinol: Insights from Yeast Studies
    Chenghua Li, Juan Wang, Bing Zhou · 2010 · Journal of Alzheimer s Disease
  39. Neuroprotective Copper Bis(thiosemicarbazonato) Complexes Promote Neurite Elongation
    Laura Bica, Jeffrey R. Liddell, Paul S. Donnelly, Clare Duncan, Aphrodite Caragounis, Irene Volitakis, Brett M. Paterson, Roberto Cappai, Alexandra Grubman, James Camakaris et al. · 2014 · PLoS ONE
  40. A Copper-Lowering Strategy Attenuates Amyloid Pathology in a Transgenic Mouse Model of Alzheimer's Disease
    Joseph F. Quinn, Christopher Harris, Katherine E. Cobb, Christopher M. Domes, Martina Ralle, George J. Brewer, Teri L. Wadsworth · 2010 · Journal of Alzheimer s Disease
  41. Increased expression of the lysosomal cholesterol transporter NPC1 in Alzheimer's disease
    Katarina Kågedal, Woojin Scott Kim, Hanna Appelqvist, Sharon L. Chan, Danni Cheng, Lotta Agholme, Kevin Jeffrey Barnham, Heather McCann, Glenda Margaret Halliday, Brett Garner · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  42. Links between copper and cholesterol in Alzheimer's disease
    Ya Hui Hung, Ashley Ian Bush, Sharon La Fontaine · 2013 · Frontiers in Physiology
  43. Metal homeostasis in Alzheimer’s disease
    Anthony Robert White, Kevin Jeffrey Barnham, Ashley Ian Bush · 2006 · Expert Review of Neurotherapeutics
  44. Structure and Synaptic Function of Metal Binding to the Amyloid Precursor Protein and its Proteolytic Fragments
    Klemens Wild, Alexander August, Claus U. Pietrzik, Stefan Kins · 2017 · Frontiers in Molecular Neuroscience
  45. The double faced role of copper in Aβ homeostasis: A survey on the interrelationship between metal dyshomeostasis, UPS functioning and autophagy in neurodegeneration
    Giuseppe Grasso, Anna Maria Santoro, Valeria Lanza, Diego Sbardella, Grazia Raffaella Tundo, Chiara Ciaccio, Stefano Marini, Massimo Coletta, Danilo Milardi · 2017 · Coordination Chemistry Reviews
  46. The role of metals in modulating metalloprotease activity in the AD brain
    Gulay Filiz, Katherine Ann Price, Aphrodite Caragounis, Tai Du, Peter John Crouch, Anthony Robert White · 2008 · European Biophysics Journal
  47. Copper and zinc bis(thiosemicarbazonato) complexes with a fluorescent tag: synthesis, radiolabelling with copper-64, cell uptake and fluorescence studies
    SinChun Lim, Katherine Ann Price, Siow‐Feng Chong, Brett M. Paterson, Aphrodite Caragounis, Kevin Jeffrey Barnham, Peter John Crouch, Josephine M. Peach, J.R. Dilworth, Anthony Robert White et al. · 2009 · JBIC Journal of Biological Inorganic Chemistry
  48. Metallostasis and amyloid β-degrading enzymes
    Giuseppe Grasso, Maria Laura Giuffrida, Enrico Rizzarelli · 2012 · Metallomics
  49. Sustained Activation of Glial Cell Epidermal Growth Factor Receptor by Bis(thiosemicarbazonato) Metal Complexes Is Associated with Inhibition of Protein Tyrosine Phosphatase Activity
    Katherine Ann Price, Aphrodite Caragounis, Brett M. Paterson, Gulay Filiz, Irene Volitakis, Colin Louis Masters, Kevin Jeffrey Barnham, Paul S. Donnelly, Peter John Crouch, Anthony Robert White · 2009 · Journal of Medicinal Chemistry
  50. MMP‐2, ‐3 and ‐9 levels and activity are not related to Aβ load in the frontal cortex in Alzheimer's disease
    Shabnam Baig, Patrick G. Kehoe, Seth Love · 2007 · Neuropathology and Applied Neurobiology
  51. Clioquinol attenuates zinc-dependent β-cell death and the onset of insulitis and hyperglycemia associated with experimental type I diabetes in mice
    Tsvia Priel, Barak Aricha-Tamir, Israel Sekler · 2007 · European Journal of Pharmacology
  52. The Copper(II)-Assisted Connection between NGF and BDNF by Means of Nerve Growth Factor-Mimicking Short Peptides
    Налетова Ирина Николаевна, Cristina Satriano, Adriana Pietropaolo, Fiorenza Gianì, Giuseppe Pandini, Viviana Triaca, Giuseppina Amadoro, Valentina Latina, Pietro Calissano, Alessio Travaglia et al. · 2019 · Cells
  53. Targeting zinc metalloenzymes in coronavirus disease 2019
    Urszula Doboszewska, Piotr Właź, Gabriel Nowak, Katarzyna Młyniec · 2020 · British Journal of Pharmacology
  54. Clioquinol Promotes Cancer Cell Toxicity through Tumor Necrosis Factor α Release from Macrophages
    Tai Du, Gulay Filiz, Aphrodite Caragounis, Peter John Crouch, Anthony Robert White · 2007 · Journal of Pharmacology and Experimental Therapeutics
  55. Targeting Biometals in Alzheimer’s Disease with Metal Chelating Agents Including Coumarin Derivatives
    Adrián Gucký, Slávka Hamuľaková · 2024 · CNS Drugs
  56. Copper in Alzheimer’s disease: too much or too little?
    Joseph F. Quinn, Susanne Crane, Christopher Harris, Teri L. Wadsworth · 2009 · Expert Review of Neurotherapeutics
  57. Metal complexes and metalloproteases: targeting conformational diseases
    Giuseppe Grasso, Sylvestre A. Bonnet · 2014 · Metallomics
  58. The Inorganic Side of NGF: Copper(II) and Zinc(II) Affect the NGF Mimicking Signaling of the N-Terminus Peptides Encompassing the Recognition Domain of TrkA Receptor
    Giuseppe Pandini, Cristina Satriano, Adriana Pietropaolo, Fiorenza Gianì, Alessio Travaglia, Diego La Mendola, Vincenzo Giuseppe Nicoletti, Enrico Rizzarelli · 2016 · Frontiers in Neuroscience
  59. A Novel hAPP/htau Mouse Model of Alzheimer's Disease: Inclusion of APP With Tau Exacerbates Behavioral Deficits and Zinc Administration Heightens Tangle Pathology
    Stephen L. P. Lippi, Meghann L. Smith, Jane M. Flinn · 2018 · Frontiers in Aging Neuroscience
  60. Cellular Copper Import by Nanocarrier Systems, Intracellular Availability, and Effects on Amyloid β Peptide Secretion
    Carina Treiber, Mohiuddin Quadir, Philipp Voigt, Michał R. Radowski, Shangjie Xu, Lisa Marie Munter, Thomas A. Bayer, Michael Schaefer, Rainer Haag, Gerd Multhaup · 2009 · Biochemistry
  61. Agents Complexing Copper as a Therapeutic Strategy for the Treatment of Alzheimers Disease
    Rosanna Squitti, Carlo Salustri · 2009 · Current Alzheimer Research
  62. Alzheimer’s Disease: Current Status of Etiopathogenesis and Therapeutic Strategies
    Mervat Ibrahim Kh, Lobna Abdel Aal Kassem · 2011 · Pakistan Journal of Biological Sciences
  63. Copper(II) Binding to PBT2 Differs from That of Other 8‑Hydroxyquinoline Chelators: Implications for the Treatment of Neurodegenerative Protein Misfolding Diseases
    Kelly L. Summers, Graham P. Roseman, George J. Sopasis, Glenn L. Millhauser, Hugh H. Harris, Ingrid J. Pickering, Graham Neil George · 2020 · Inorganic Chemistry
  64. Metal attenuating therapies in neurodegenerative disease
    Alexandra I. Mot, Anthony G. Wedd, Layla Sinclair, David R. Brown, Steven John Collins, Marcus W. Brazier · 2011 · Expert Review of Neurotherapeutics
  65. The MMP-2/TIMP-2 System in Alzheimer Disease
    Hongyue Wang, Longjian Huang, Lei Wu, Jiaqi Lan, Xinhong Feng, Pingping Li, Ying Peng · 2020 · CNS & Neurological Disorders - Drug Targets
  66. Genetic Variability in Molecular Pathways Implicated in Alzheimer's Disease: A Comprehensive Review
    David Vogrinc, Katja Goričar, Vita Dolžan · 2021 · Frontiers in Aging Neuroscience
  67. Oral Zinc Reduces Amyloid Burden in Tg2576 Mice
    Christopher Harris, Kellen Voss, Charles Murchison, Martina Ralle, Kate Frahler, Raina Carter, Allison Rhoads, Betty Lind, Emily Robinson, Joseph F. Quinn · 2014 · Journal of Alzheimer s Disease
  68. Plasma gelsolin and matrix metalloproteinase 3 as potential biomarkers for Alzheimer disease
    Peng Mao, Jianping Jia, Wei Qin · 2015 · Neuroscience Letters
  69. Metalloproteinases and Metalloproteinase Inhibitors in Age-Related Diseases
    Simona Gargiulo, Paola Gamba, Giuseppe Poli, Gabriella Leonarduzzi · 2014 · Current Pharmaceutical Design
  70. Metals, Membranes, and Amyloid-β Oligomers: Key Pieces in the Alzheimer's Disease Puzzle?
    Andrew D. Watt, Victor L. Villemagne, Kevin Jeffrey Barnham · 2012 · Journal of Alzheimer s Disease
  71. Metallo-complex activation of neuroprotective signalling pathways as a therapeutic treatment for Alzheimer’s disease
    Laura Bica, Peter John Crouch, Roberto Cappai, Anthony Robert White · 2008 · Molecular BioSystems
  72. A new role for matrix metalloproteinase-3 in the NGF metabolic pathway: Proteolysis of mature NGF and sex-specific differences in the continuum of Alzheimer's pathology
    Pentz, Rowan, Iulita, M. Florencia, Mikutra-Cencora, Maya, Ducatenzeiler, Adriana, Bennett, David A., Cuello, A. Claudio · 2021 · Neurobiology of Disease
  73. The absence of myelin basic protein promotes neuroinflammation and reduces amyloid β-protein accumulation in Tg-5xFAD mice
    Ou-Yang, Ming-Hsuan, Van Nostrand, William E · 2013 · Journal of Neuroinflammation
  74. Analysis of the Relationship Between Metalloprotease-9 and Tau Protein in Alzheimer’s Disease
    Mario Hernándes‐Alejandro, Sarita Montaño, Charles R. Harrington, Claude M. Wischik, Andrés Salas‐Casas, Pedro Cortés‐Reynosa, Eduardo Pérez Salazar, Javier Cázares-Ápatiga, Ricardo Apátiga-Pérez, Miguel Ángel Ontiveros‐Torres et al. · 2020 · Journal of Alzheimer s Disease
  75. α-Lipoic Acid Has the Potential to Normalize Copper Metabolism, Which Is Dysregulated in Alzheimer’s Disease
    Kristel Metsla, Sigrid Kirss, Katrina Laks, Gertrud Sildnik, Mari Palgi, Teele Palumaa, Vello Tõugu, Peep Palumaa · 2021 · Journal of Alzheimer s Disease
  76. Copper, endoproteolytic processing of the prion protein and cell signalling
    Cathryn L. Haigh · 2010 · Frontiers in bioscience
  77. A copper-binding site in the cytoplasmic domain of BACE1 identifies a possible link to metal homoeostasis and oxidative stress in Alzheimer's disease
    C. Dingwall · 2007 · Biochemical Society Transactions
  78. Effect of Metal Chelators on γ-Secretase Indicates That Calcium and Magnesium Ions Facilitate Cleavage of Alzheimer Amyloid Precursor Substrate
    Michael Ho, D. Hoke, Jia-Chua Yee, Qiao-Xin Li, J. Culvenor, C. Masters, A. White, G. Evin · 2010 · International Journal of Alzheimer's Disease
  79. Protective Effects of Vitamin E against Oxidative Damage Induced by Aβ1–40Cu(II) Complexes
    Xueling Dai, Yaxuan Sun, Zhao-Feng Jiang · 2007 · Acta Biochimica et Biophysica Sinica
  80. Alzheimer’s Drug PBT2 Interacts with the Amyloid β 1–42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs
    Kelly L. Summers, Graham P. Roseman, Kevin M. Schilling, Natalia V. Dolgova, M. Jake Pushie, Dimosthenis Sokaras, Thomas Kröll, Hugh H. Harris, Glenn L. Millhauser, Ingrid J. Pickering et al. · 2022 · Inorganic Chemistry
  81. Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways
    Niall Steven Kenneth, George Hucks, Andrew J. Kocab, Annie McCollom, Colin S. Duckett · 2014 · Cell Cycle
  82. Clioquinol inhibits peroxide-mediated toxicity through up-regulation of phosphoinositol-3-kinase and inhibition of p53 activity
    Gulay Filiz, Aphrodite Caragounis, Laura Bica, Tai Du, Colin Louis Masters, Peter John Crouch, Anthony Robert White · 2007 · The International Journal of Biochemistry & Cell Biology
  83. Construction of Hybrid Fluorescent Sensor for Cu2+ Detection Using Fluorescein-functionalized CdS Quantum Dots Via FRET
    Kun Wang, Erfei Dong, Min Fang, Weiju Zhu, Cun Li · 2022 · Journal of Fluorescence
  84. Clioquinol Inhibits Zinc-Triggered Caspase Activation in the Hippocampal CA1 Region of a Global Ischemic Gerbil Model
    Tao Wang, Wei Zheng, He Jax Xu, Jiamin Zhou, Zhan‐You Wang · 2010 · PLoS ONE
  85. MRZ-99030 – A novel modulator of Aβ aggregation: II – Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice
    Gerhard Rammes, Andreas Gravius, Maarten Ruitenberg, Nico Wegener, Caroline Chambon, Kamila Sroka, Ross Jeggo, Lydia E. Staniaszek, David C. Spanswick, Eugene O‘Hare et al. · 2015 · Neuropharmacology
  86. Proteolytic α-Synuclein Cleavage in Health and Disease
    Alexandra Bluhm, Sarah Schrempel, Stephan von Hörsten, Anja Schulze, Steffen Roßner · 2021 · International Journal of Molecular Sciences
  87. Activation of epidermal growth factor receptor by metal-ligand complexes decreases levels of extracellular amyloid beta peptide
    Katherine Ann Price, Gulay Filiz, Aphrodite Caragounis, Tai Du, Katrina M. Laughton, Colin Louis Masters, Robyn A. Sharples, Andrew Francis Hill, Qiao‐Xin Li, Paul S. Donnelly et al. · 2008 · The International Journal of Biochemistry & Cell Biology
  88. Regulation of neuroinflammation in Alzheimer's disease via nanoparticle-loaded phytocompounds with anti-inflammatory and autophagy-inducing properties
    Vinayak Nayak, Sushmita Patra, Shrushti Rout, Atala Bihari Jena, Rohit Sharma, Kali Prasad Pattanaik, Jay Singh, Shyam Sunder Pandey, Ravindra Pratap Singh, Sanatan Majhi et al. · 2023 · Phytomedicine
  89. Neprilysin-Mediated Amyloid Beta Clearance and Its Therapeutic Implications in Neurodegenerative Disorders
    Shailendra Kumar Saxena, Saniya Ansari, Vimal K. Maurya, Swatantra Kumar, Deepak Kumar Sharma, HardeepSingh Malhotra, Sneham Tiwari, Chhitij Srivastava, Janusz Tadeusz Paweska, Ahmed Sayed Abdel-Moneim et al. · 2024 · ACS Pharmacology & Translational Science
  90. Effects of Leptin on Lipopolysaccharide-Induced Remodeling in an In Vitro Model of Human Myometrial Inflammation1
    Maëva Wendremaire, Pascal Mourtialon, Françoise Goirand, Frédéric Lirussi, Marina Barrichon, Tarik Hadi, Carmen Garrido, Isabelle Le Ray, Monique Dumas, Paul Sagot et al. · 2013 · Biology of Reproduction
  91. Clioquinol and vitamin B12 (cobalamin) synergistically rescue the lead-induced impairments of synaptic plasticity in hippocampal dentate gyrus area of the anesthetized rats in vivo
    W.-H. Chen, M. Wang, Shanshan Yu, L. Su, Da‐Miao Zhu, J.-Q. She, Xiujing Cao, D.-Y. Ruan · 2007 · Neuroscience
  92. Targeting metals rescues the phenotype in an animal model of tauopathy
    Amelia Sedjahtera, Lydia Gunawan, Lisa Bray, Lin Wai Hung, Jack Parsons, Nobuyuki Okamura, Victor L. Villemagne, Kazuhiko Yanai, Xiang M. Liu, Jacky Chan et al. · 2018 · Metallomics
  93. Simvastatin Treatment Preserves Synaptic Plasticity in AβPPswe/PS1dE9 Mice
    Charles Métais, Kathryn Brennan, Alexandra J. Mably, Michael Scott, Dominic M. Walsh, Caroline E. Herron · 2014 · Journal of Alzheimer s Disease
  94. GnRH-(1-5) activates matrix metallopeptidase-9 to release epidermal growth factor and promote cellular invasion.
    Madelaine J. Cho-Clark, D. O. Larco, B. Zahn, S. Mani, T. J. Wu · 2015 · Molecular and Cellular Endocrinology
  95. PBT2 inhibits glutamate-induced excitotoxicity in neurons through metal-mediated preconditioning
    Timothy Johanssen, Nuttawat Suphantarida, Paul S. Donnelly, Xiang M. Liu, Steven Petrou, Andrew Francis Hill, Kevin Jeffrey Barnham · 2015 · Neurobiology of Disease
  96. Trophoblast survival signaling during human placentation requires HSP70 activation of MMP2-mediated HBEGF shedding
    Chandni V. Jain, Philip Jessmon, Charbel T. Barrak, Alan D. Bolnick, Brian A. Kilburn, Michael Hertz, David Randall Armant · 2017 · Cell Death and Differentiation
  97. PBT2 acts through a different mechanism of action than other 8-hydroxyquinolines: an X-ray fluorescence imaging study
    Kelly L. Summers, Natalia V. Dolgova, Kenneth B. Gagnon, George J. Sopasis, Ashley K. James, Barry Chi Hong Lai, Nicole J. Sylvain, Hugh H. Harris, Helen K. Nichol, Graham Neil George et al. · 2020 · Metallomics
  98. Elevation in Sphingomyelin Synthase Activity Is Associated with Increases in Amyloid-Beta Peptide Generation
    Jen-Hsiang T. Hsiao, YuHong Fu, Andrew Francis Hill, Glenda Margaret Halliday, Woojin Scott Kim · 2013 · PLoS ONE
  99. Anti-Copper Therapies in Alzheimers Disease: New Concepts
    Rosanna Squitti, Giancarlo Zito · 2009 · Recent Patents on CNS Drug Discovery
  100. Modulation of amyloid precursor protein processing by synthetic ceramide analogues
    Hongyun Li, Woojin Scott Kim, Gilles J. Guillemin, Andrew Francis Hill, Genevieve M. Evin, Brett Garner · 2010 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids